Medikit Co EBIT per Share
The EBIT per Share of Medikit Co (7749.T) as of Aug 26, 2026 is 304.46 JPY. In the previous year, EBIT per Share was 286.20 JPY — a change of 6.38% (higher).
Get this data via API
Financial Data API
EBIT per Share
304.46JPY
YoY
6.38%
Last updated:
EBIT per Share of Medikit Co is 2026 304.46 JPY. EBIT per Share of Medikit Co was 2025 286.20 JPY. It decreases by 6.38% higher compared to the previous year.
The Medikit Co EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2018
214.29 JPY
Jan 1, 2019
227.43 JPY
Jan 1, 2020
254.98 JPY
Jan 1, 2021
223.44 JPY
Jan 1, 2022
263.00 JPY
Jan 1, 2023
245.12 JPY
Jan 1, 2024
286.20 JPY
Jan 1, 2025
304.46 JPY
| YEAR | EBIT per Share | YoY |
|---|---|---|
| 304.46JPY | +6.38% | |
| 286.20JPY | +16.76% | |
| 245.12JPY | -6.80% | |
| 263.00JPY | +17.70% | |
| 223.44JPY | -12.37% | |
| 254.98JPY | +12.11% | |
| 227.43JPY | +6.13% | |
| 214.29JPY | +3.53% | |
| 206.99JPY | -2.55% | |
| 212.40JPY | +13.24% | |
| 187.56JPY | -46.27% | |
| 349.11JPY | +3.15% | |
| 338.44JPY | -16.93% | |
| 407.44JPY | +3.38% | |
| 394.11JPY | +18.43% | |
| 332.78JPY | +12.93% | |
| 294.67JPY | +2.12% | |
| 288.56JPY | -5.22% | |
| 304.44JPY | -11.44% | |
| 343.78JPY | — |
Access this data via the Eulerpool API
Medikit Co Stock analysis
What does Medikit Co do? The history of the company Medikit Co Ltd dates back to the 1970s, when the company was founded as a small family business in Japan. Over time, Medikit grew into a multinational company with offices in Asia, Europe, and North America.
Medikit's business model is focused on developing, manufacturing, and selling innovative medical devices and consumables. The company specializes in three areas: Medical Instruments, Medical Consumables, and Medical Technology.
In the field of Medical Instruments, Medikit offers a wide range of products for use in diagnosis and therapy. These include endoscopes for examining hollow organs such as the stomach and intestines, as well as flexible endoscopes for examining bronchi and lungs. In addition, the range includes ultrasound devices for diagnosing heart, blood vessel, and musculoskeletal disorders, as well as surgical instruments for use in minimally invasive surgery.
In the field of Medical Consumables, Medikit offers bandages, injection and infusion sets, catheters and urinary drainage systems, as well as blood collection systems. Products for home care, such as ostomy care and incontinence supplies, are also part of the portfolio.
In the field of Medical Technology, Medikit offers technologies for telemedicine and hospital routine. These include systems for wireless transmission of vital parameters such as blood pressure and heart rate, as well as data storage and processing systems for medical examination data.
Medikit is constantly striving to improve its products and offer customers the best products. This has resulted in Medikit having one of the best research and development departments in medical technology. Research is conducted, among other things, on better diagnostic procedures and new surgical methods.
Another important aspect of Medikit's business model is to work closely with medical facilities and professionals to better understand the needs of customers and offer them customized solutions. This is also reflected in the numerous trainings and workshops that Medikit offers for medical professionals.
Overall, Medikit Co Ltd has established itself as a reliable and innovative provider in medical technology. By combining top-notch products with excellent service, the company demonstrates that it stands by its customers in every situation. Medikit Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Medikit Co stock
EBIT per Share of Medikit Co is 304.46 JPY in 2026.
EBIT per Share of Medikit Co changed from 286.20 JPY to 304.46 JPY, representing a 6.38% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Medikit Co since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Medikit Co
All Key Metrics — Medikit Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth